Growth Metrics

Oculis Holding AG (OCS) EBIAT (2022 - 2026)

Quarterly EBIAT changed 0.26% to -$36.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$21.2 billion through Mar 2026, up 9.53% year-over-year, with the annual reading at -$123.8 million for FY2025, 26.45% down from the prior year.

Oculis Holding AG's EBIAT history spans 5 years, with the latest figure at -$36.8 million for Q1 2026.

  • EBIAT came in at -$36.8 million for Q1 2026, down from -$29.4 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of -$9.5 million in Q4 2022 to a low of -$23.3 billion in Q3 2024.
  • The 5-year median for EBIAT is -$26.2 million (2025), against an average of -$2.8 billion.
  • The largest YoY upside for EBIAT was 62.94% in 2024 against a maximum downside of 118106.55% in 2024.
  • Oculis Holding AG's EBIAT stood at -$9.5 million in 2022, then crashed by 47.82% to -$14.1 million in 2023, then tumbled by 132.14% to -$32.7 million in 2024, then increased by 10.06% to -$29.4 million in 2025, then dropped by 25.23% to -$36.8 million in 2026.
  • Per Business Quant, the three most recent readings for OCS's EBIAT are -$36.8 million (Q1 2026), -$29.4 million (Q4 2025), and -$21.1 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIAT (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -2.99 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 30.90 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.03 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 727.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -3.63 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 205.99 Mn
10 Oculis Holding AG 24.51 Bn 24.21 Bn - -36.84 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -36.84 Mn
Dec 31, 2025 -29.42 Mn
Sep 30, 2025 -21.07 Bn
Jun 30, 2025 -30.65 Mn
Mar 31, 2025 -36.94 Mn
Dec 31, 2024 -32.71 Mn
Sep 30, 2024 -23.30 Bn
Jun 30, 2024 -23.04 Mn
Mar 31, 2024 -18.44 Mn
Dec 31, 2023 -14.09 Mn
Sep 30, 2023 -19.71 Mn
Jun 30, 2023 -14.32 Mn
Mar 31, 2023 -49.75 Mn
Dec 31, 2022 -9.53 Mn
Sep 30, 2022 -10.31 Mn
Jun 30, 2022 -12.82 Mn